Alphatec Holdings

ATEC

Market cap $2.02B

Over the course of 2025, Alphatec Holdings or "ATEC" has continued to outperform sales expectations and taken additional share in the $8 billion U.S. spinal disorder treatment market. In addition, the company has delivered vastly improved profitability and cash flow. While moderately lower growth expectations for 2026 appear to have impacted the stock price in recent weeks, I would consider the selloff a buying opportunity.

Alphatec (ATEC) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.23 per share a year ago.

Alphatec Holdings, Inc. (ATEC) Q4 2025 Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Quarter Ended December 31, 2025 Year Ended December 31, 2025 Total revenue $213 million $764 million GAAP gross margin 70% 70% Non-GAAP gross margin 71% 7.

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Craig E. Hunsaker, EVP, People & Culture at Alphatec Holdings, sold 32,584 shares for a transaction value of $679,050.56 at $20.84 per share on Dec. 10, 2025. The sale represented 2.53% of Hunsaker's direct holdings, reducing his stake from 1,289,142 to 1,256,558 shares.

Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md.

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended De.

Miles Patrick, the CEO of Alphatec Holdings, sold 100,000 shares of the company for about $2.1 million, according to a recent Form 4. This sale represented 1.82% of Miles Patrick's direct holdings, reducing direct ownership to 5.14 million shares.